Immix Biopharma IMMX
NASDAQ IMMX
$10.23 -0.18 (-1.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immix Biopharma (IMMX) Accumulated Depreciation (2023)

Updated

Immix Biopharma (IMMX) recorded Accumulated Depreciation of $14,314 in Q1 2023.

Analysis

Immix Biopharma (IMMX) Accumulated Depreciation (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immix Biopharma 743.97 Mn 743.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 14,314.00
API Access

Immix Biopharma Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=IMMX&period=max&api_key=YOUR_API_KEY